This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Lung Cancer Alliance Gratified That Federal Funding For Lung Cancer Research Maintained In The FY2013 Continuing Resolution

$10.5 million funding for Department of Defense Lung Cancer Research Program Included Despite Threats of Sequestration 

WASHINGTON, March  21, 2013 /PRNewswire-USNewswire/ -- Today, Lung Cancer Alliance (LCA) commends the US Congress on the passage of a Continuing Resolution for the remainder of FY2013 that includes $10.5 million in funding for the Department of Defense (DOD) Lung Cancer Research Program. This would bring the total funding so far for this program, which was established in 2009, to nearly $70 million.

Through the efforts of Lung Cancer Alliance, the Lung Cancer Research Program (LCRP) was established within the Department of Defense (DOD) Congressionally Directed Medical Research Program (CDMRP) and allocated an initial $20 million to fund early detection research targeting at-risk military.

"With the specter of sequestration hanging over so many important programs, continued funding for the lung cancer screening program and all other programs within the CDMRP is deeply gratifying," stated Lung Cancer Alliance President and CEO, Laurie Fenton Ambrose

"Securing increased federal research funding for all aspects of lung cancer has been, and will continue to be, a core priority of our organization," Fenton Ambrose added. "And we remain grateful to congressional leaders for their continued backing of this specific and important program."

Lung cancer is the leading cause of cancer death among men and women and every ethnic group and takes more lives each year than breast, prostate, colon and pancreatic cancers combined.

Without screening, the majority of lung cancers are diagnosed at such a late stage that the five year survival rate is only 15%—virtually unchanged since the 1971 declaration of "War on Cancer."

Lung Cancer Alliance (LCA), www.lungcanceralliance.org, is committed to ending injustice and saving lives through an alliance of advocacy, education, and support. LCA provides live, professional support, referral and information services for patients, their loved ones and those at risk for lung cancer; advocates for multiple millions in public health dollars for lung cancer research; and conducts national awareness campaigns.

Follow Lung Cancer Alliance on Facebook: www.facebook.com/lungcanceralliance. Follow us on Twitter: @LCAorg.

CONTACT Kay Cofrancesco202-742-1422 kay@lungcaneralliance.org

SOURCE Lung Cancer Alliance

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.13 -82.86 -0.46%
S&P 500 2,114.68 -8.80 -0.41%
NASDAQ 5,084.9860 -21.6070 -0.42%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs